PreXion CEO

May 24, 2011
Dr. Saito was the founder of PreXion, and since 2007, has served as chairman of the company.

SAN MATEO, California--PreXion, a leader in high quality 3-D Cone Beam CT Imaging systems for dentistry, has announced the naming of Motoaki Saito, MD, PhD, as chief executive officer. Dr. Saito was the founder of PreXion, and since 2007, has served as chairman of the company.

To read more about PreXion, go to PreXion.

In 1997, Dr. Saito founded TeraRecon (www.terarecon.com ), a leader of technology solutions of advanced 3-D imaging systems for medical and industrial applications. Dr. Saito served as TeraRecon's CEO for the first 12 years, and CTO the last two years of the company's history. He is currently chairman of the Board of Directors.

Dr. Saito is a radiologist, entrepreneur, inventor, and visionary with numerous patents to his name. His academic research and clinical training at the University of Tokyo Hospital provided him with experience with medical imaging modalities and information systems.

In addition to strategic planning of the company's operations and growth, he was responsible for the solution/application ground designs and the core technology designs, including system/processor level architecture.

Dr. Saito received his B.Sc. degree in medicine from Niigata University and passed the Japanese National Medical Practitioners Qualifying Examination in 1992. In 2004, he received his PhD in radiology and biomedical engineering, Graduate School of Medicine, the University of Tokyo.

Dr. Saito said, "I am honored to take over the leadership of PreXion in a time of accelerated growth, expansion, and implementation of important technical and clinical advancements. Due to our industry leading high quality images, powerful and intuitive software, and excellent customer support, PreXion has become a leader in the dental 3-D imaging/cone beam market. We are making significant investments in R&D with a focus on continuing to increase image quality and diagnostic capability while lowering radiation exposure. I will play a strong role in developing innovative and the most advanced new generation scanners and imaging solutions, even beyond the current CBCT technology.

"PreXion is well-positioned for aggressive growth as a leader in clinical, technical, and diagnostic capabilities of our advanced 3-D CBCT Imaging systems. I look forward to working with Robert Meier, our president and COO, and the other members of our senior management team. We have developed a strong team internally, across the U.S. and internationally, which has resulted in significant growth and gains in market share in 2010 with an especially strong Q4 and into 2011," added Dr. Saito.

For more information, go to www.prexion.com.

To comment on this subject, go to community.pennwelldentalgroup.com/.